This is good news for the current LANI phase III trial. LANI is being compared to Tamiflu and apparently Tamiflu doesn't work in a common strain of flu this year. Lucky timing for the trial! I'd expect to see LANI beat Tamiflu in terms of efficacy.
"The Institute separately examined samples of the Soviet-A strain taken from 35 patients in 11 prefectures, and found that Tamiflu was ineffective for 34 of the patients, or 97 percent. "
BTA Price at posting:
41.0¢ Sentiment: Buy Disclosure: Held